Compared to Estimates, Steris (STE) Q3 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2222953/compared-to-estimates-steris-ste-q3-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2222953
Feb 07, 2024 - The headline numbers for Steris (STE) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Why Steris (STE) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2226893/why-steris-ste-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2226893
Feb 15, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Here's Why Investors Should Retain STERIS (STE) Stock for Now
https://www.zacks.com/stock/news/2232656/here-s-why-investors-should-retain-steris-ste-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2232656
Feb 27, 2024 - Investors are optimistic about STERIS (STE) on continuous recovery of healthcare procedures and upbeat 2024 guidance.
0
Here's Why Investors Should Retain STERIS (STE) Stock for Now
https://www.zacks.com/stock/news/2247607/here-s-why-investors-should-retain-steris-ste-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2247607
Mar 28, 2024 - Investors are optimistic about STERIS (STE) on strong Healthcare business performance and raised 2024 guidance.
0
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
https://www.zacks.com/commentary/2255364/3-medical-instruments-stocks-to-buy-amid-improving-industry-trends?cid=CS-ZC-FT-industry_outlook-2255364
Apr 15, 2024 - The Zacks Medical - Instruments industry is expected to gain from the rising adoption of smart healthcare options, including genAI. However, supply issues and staffing shortages continue to disrupt growth. EW, DXCM and STE appear well-poised to brave the challenges.
0
Top Stock Reports for Micron Technology, Anheuser-Busch & Duke Energy
https://www.zacks.com/commentary/2266711/top-stock-reports-for-micron-technology-anheuser-busch-duke-energy?cid=CS-ZC-FT-research_daily-2266711
May 02, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Micron Technology, Inc. (MU), Anheuser-Busch InBev SA/NV (BUD) and Duke Energy Corporation (DUK).
0
Why Steris (STE) is a Top Growth Stock for the Long-Term
https://www.zacks.com/stock/news/2224796/why-steris-ste-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2224796
Feb 12, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Here's Why Steris (STE) is Poised for a Turnaround After Losing -9.06% in 4 Weeks
https://www.zacks.com/stock/news/2252552/here-s-why-steris-ste-is-poised-for-a-turnaround-after-losing-9-06-in-4-weeks?cid=CS-ZC-FT-tale_of_the_tape|rsi-2252552
Apr 09, 2024 - The heavy selling pressure might have exhausted for Steris (STE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
0
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2267512/sight-sciences-inc-sght-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2267512
May 02, 2024 - Sight Sciences (SGHT) delivered earnings and revenue surprises of -13.79% and 5.06%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
0
Pages: 1
Page 1